Maximizing the value of the open label extension phase of randomized clinical trials. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40620-022-01542-3

PubMed Identifier: 36607562

Publication URI: http://europepmc.org/abstract/MED/36607562

Type: Journal Article/Review

Volume: 36

Parent Publication: Journal of nephrology

Issue: 6

ISSN: 1121-8428